CJC-1295 DAC (2mg) Dosage Protocol
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic GHRH analog with extended half-life (~6 days). The DAC modification allows for once or twice weekly dosing.
Add 2.0 mL bacteriostatic water → 1 mg/mL (1000 mcg/mL)
600mcg-2mg once or twice weekly
At 1 mg/mL: 60 units = 600 mcg, 100 units = 1mg
Lyophilized: -20°C; Reconstituted: 2-8°C for up to 4 weeks
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Weeks 1-4 | 600 mcg twice weekly | 60 units per dose |
| Weeks 5-8 | 1mg twice weekly | 100 units per dose |
| Weeks 9-12 | 1-2mg once weekly | 100-200 units weekly |
- 1Draw 2.0 mL bacteriostatic water with a sterile syringe
- 2Inject slowly down the vial wall to prevent foaming
- 3Gently swirl until fully dissolved - do not shake
- 4Label with date and concentration, refrigerate immediately
CJC-1295 DAC is a modified GHRH (1-29) analog with a Drug Affinity Complex that extends half-life to approximately 6 days. Clinical studies showed prolonged stimulation of GH and IGF-1 levels. The DAC binds to albumin, preventing rapid degradation.
- Extended half-life allows less frequent dosing
- Stimulates natural growth hormone release
- May increase IGF-1 levels
- Supports recovery and body composition
- Teichman SL, et al. Prolonged stimulation of GH and IGF-1. J Clin Endocrinol Metab. 2006;91(3):799-805
- FDA-2024-N-4777 - CJC-1295 Documentation
Lyophilized
Store at -20°C, protected from light
Reconstituted
Refrigerate at 2-8°C, use within 4 weeks
Best administered on empty stomach, 2-3 hours after eating
- •Research compound - not FDA approved
- •Best dosed on empty stomach for optimal absorption
- •May cause water retention initially
- •Often combined with GHRP for synergistic effects
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.